The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 63 results:
Author [ Title(Desc)] Type Year
Filters: Keyword is Renal Insufficiency, Chronic  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Sarafidis, P. A., Georgianos P. I., & Bakris G. L. (2015).  Advances in treatment of hyperkalemia in chronic kidney disease.. Expert Opin Pharmacother. 16(14), 2205-15.
Sarafidis, P. A., & Ruilope L. M. (2014).  Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation?. Kidney Int. 85(3), 536-46.
Kirmizis, D., Papagianni A., Dogrammatzi F., Efstratiadis G., & Memmos D. (2013).  Anti-inflammatory effects of simvastatin in diabetic compared to non-diabetic patients on chronic hemodialysis.. J Diabetes. 5(4), 492-4.
Georgianos, P. I., Sarafidis P. A., & Liakopoulos V. (2015).  Arterial Stiffness: A Novel Risk Factor for Kidney Injury Progression?. Am J Hypertens. 28(8), 958-65.
Roumeliotis, S., Dounousi E., Eleftheriadis T., & Liakopoulos V. (2019).  Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review.. Int J Mol Sci. 20(3), 
Heerspink, H. J. L., Parving H-H., Andress D. L., Bakris G., Correa-Rotter R., Hou F-F., et al. (2019).  Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.. Lancet. 393(10184), 1937-1947.
Sarafidis, P. A., & Ruilope L. M. (2014).  The authors reply.. Kidney Int. 86(4), 855.
B
Sarafidis, P. A., Ruilope L. M., Loutradis C., Gorostidi M., de la Sierra A., de la Cruz J. J., et al. (2018).  Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patients.. J Hypertens. 36(5), 1076-1085.
Karava, V., Printza N., Dotis J., Demertzi D., Antza C., Kotsis V., et al. (2019).  Body composition and arterial stiffness in pediatric patients with chronic kidney disease.. Pediatr Nephrol. 34(7), 1253-1260.
C
Sarafidis, P. A., & Bakris G. L. (2015).  Cardiovascular disease in CKD in 2014: new insights into cardiovascular risk factors and outcomes.. Nat Rev Nephrol. 11(2), 70-2.
Athyros, V. G., Tziomalos K., Katsiki N., Doumas M., Karagiannis A., & Mikhailidis D. P. (2015).  Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.. World J Gastroenterol. 21(22), 6820-34.
Duni, A., Liakopoulos V., Rapsomanikis K-P., & Dounousi E. (2017).  Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the Burden?. Oxid Med Cell Longev. 2017, 9036450.
Papademetriou, V., Nylen E. S., Doumas M., Probstfield J., Mann J. F. E., Gilbert R. E., et al. (2017).  Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study.. Am J Med. 130(12), 1465.e27-1465.e39.
Georgianos, P. I., Eleftheriadis T., & Liakopoulos V. (2023).  Combination therapy with an SGLT-2 inhibitor and finerenone in DKD: Are we there yet?. Eur J Clin Invest. 53(2), e13864.
Sarafidis, P. A., Georgianos P. I., & Zebekakis P. E. (2014).  Comparative epidemiology of resistant hypertension in chronic kidney disease and the general hypertensive population.. Semin Nephrol. 34(5), 483-91.
D
Moralidis, E., Papanastasiou E., Didangelos T., Hilidis I., Siountas A., & Arsos G. (2020).  Determination of the glomerular filtration rate in patients with type 2 diabetes: An assessment of the agreement between Cr-EDTA plasma clearance and Tc-DTPA plasma clearance, Tc-DTPA renography and plasma creatinine prediction equation.. Diabetes Res Clin Pract. 161, 108079.
Roumeliotis, S., Roumeliotis A., Dounousi E., Eleftheriadis T., & Liakopoulos V. (2019).  Dietary Antioxidant Supplements and Uric Acid in Chronic Kidney Disease: A Review.. Nutrients. 11(8), 
Gorostidi, M., Sarafidis P. A., de la Sierra A., Segura J., de la Cruz J. J., Banegas J. R., et al. (2013).  Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: A 5,693-patient cross-sectional analysis from Spain.. Am J Kidney Dis. 62(2), 285-94.
E
Papademetriou, V., Lovato L., Tsioufis C., Cushman W., Applegate W. B., Mottle A., et al. (2017).  Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study.. Am J Nephrol. 45(2), 136-145.
Alexandrou, M-E., Papagianni A., Tsapas A., Loutradis C., Boutou A., Piperidou A., et al. (2019).  Effects of mineralocorticoid receptor antagonists in proteinuric kidney disease: a systematic review and meta-analysis of randomized controlled trials.. J Hypertens. 37(12), 2307-2324.
Georgianos, P. I., Liampas I., Kyriakou A., Vaios V., Raptis V., Savvidis N., et al. (2017).  Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease.. Int Urol Nephrol. 49(12), 2217-2221.
G
Ruiz-Hurtado, G., Sarafidis P., Fernández-Alfonso M. S., Waeber B., & Ruilope L. M. (2016).  Global cardiovascular protection in chronic kidney disease.. Nat Rev Cardiol. 13(10), 603-8.
Iliadis, F., Didangelos T., Ntemka A., Makedou A., Moralidis E., Gotzamani-Psarakou A., et al. (2011).  Glomerular filtration rate estimation in patients with type 2 diabetes: creatinine- or cystatin C-based equations?. Diabetologia. 54(12), 2987-94.
H
Sarafidis, P. A., Persu A., Agarwal, iv R., Burnier M., de Leeuw P., Ferro C., et al. (2017).  Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kid. J Hypertens. 35(4), 657-676.
I
Athyros, V. G., Tziomalos K., Katsiki N., Gossios T. D., Giouleme O., Anagnostis P., et al. (2013).  The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study.. Curr Vasc Pharmacol. 11(5), 779-84.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.